drugset / Trial / NCT00848497

Testosterone for Penile Rehabilitation After Radical Prostatectomy

NCT00848497 ↗

Phase 0 Terminated 3 enrolled Mohit Khera
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to determine the effectiveness of testosterone replacement therapy (TRT) in men following surgery to remove the prostate in improving erectile function. Subjects will be randomized (like flipping a coin) to one of two groups. One group will receive Testim® (testosterone gel) 5 g per day plus Viagra 25 mg every night and the other will receive Placebo-Testim® 5 g per day plus Viagra 25 mg every night. Subjects will begin drug treatment 3 months after the initial screening visit and will take study drug for 3 months only. Participation will end at the end of the 6-month visit.

Timeline

Start
2007-11
Primary completion
2013-03
Completion
2013-03

Outcome

Outcome not reported

Stopped (Business): “Lack of volunteers who would consent to participate and lack of funding”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Testosterone Small molecule 50 mg —
Comparator Sildenafil Unknown 25 mg —